Here’s how an AstraZeneca spinout deal gets done – Baltimore Business Journal

By adminNovember 5, 2018May 22nd, 2025No Comments

Here’s how an AstraZeneca spinout deal gets done – Baltimore Business Journal

AstraZeneca PLC’s research and development arm MedImmune Inc. spun off a small biotech startup company called Viela Bio.

{iframe}https://www.bizjournals.com/baltimore/news/2018/10/30/here-s-how-an-astrazeneca-spinout-deal-gets-done.html{/iframe}